Sensome

Sensome is the pioneer of groundbreaking microsensing technology for real-time intra-operative tissue analysis. It combines the world's smallest impedance-based sensor with predictive algorithms to identify and characterize biological tissues in situ. Initial applications include identifying cancerous lung cancer tumors during biopsy, and characterizing clot involved in ischemic stroke and peripheral vascular disease to optimize treatment. The company’s unique technology is based on electrical impedance spectroscopy, which measures the characteristics of tissue in 360° surrounding the sensor. The microscopic size and flexibility of the proprietary technology enables it to be incorporated into a variety of medical devices. Sensome is partnered with leading guidewire manufacturer ASAHI INTECC for manufacturing of the Clotild® Smart Guidewire System for ischemic stroke. Sensome is EN ISO 13485:2016 certified. Got a suspicious job offer that did not originate from an official Sensome source? Please check our disclaimer on recruitment fraud: